ATE262896T1 - Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern - Google Patents

Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Info

Publication number
ATE262896T1
ATE262896T1 AT98928504T AT98928504T ATE262896T1 AT E262896 T1 ATE262896 T1 AT E262896T1 AT 98928504 T AT98928504 T AT 98928504T AT 98928504 T AT98928504 T AT 98928504T AT E262896 T1 ATE262896 T1 AT E262896T1
Authority
AT
Austria
Prior art keywords
vitamin
ldl
oxidation
lycopine
prevent
Prior art date
Application number
AT98928504T
Other languages
English (en)
Inventor
Bianca Fuhrman
Michael Aviram
Zohar Nir
Morris Zelkha
Original Assignee
Lycored Natural Prod Ind Ltd
Bianca Fuhrman
Michael Aviram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12111297A external-priority patent/IL121112A/xx
Priority claimed from IL12493098A external-priority patent/IL124930A0/xx
Application filed by Lycored Natural Prod Ind Ltd, Bianca Fuhrman, Michael Aviram filed Critical Lycored Natural Prod Ind Ltd
Application granted granted Critical
Publication of ATE262896T1 publication Critical patent/ATE262896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT98928504T 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern ATE262896T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12111297A IL121112A (en) 1997-06-19 1997-06-19 Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
IL12493098A IL124930A0 (en) 1998-06-16 1998-06-16 Natural compositions for the prevention of ldl oxidation
PCT/IL1998/000286 WO1998057622A1 (en) 1997-06-19 1998-06-18 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation

Publications (1)

Publication Number Publication Date
ATE262896T1 true ATE262896T1 (de) 2004-04-15

Family

ID=26323453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928504T ATE262896T1 (de) 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Country Status (8)

Country Link
EP (1) EP0996431B1 (de)
JP (1) JP2002504928A (de)
AT (1) ATE262896T1 (de)
AU (1) AU8031998A (de)
DE (1) DE69822834T2 (de)
DK (1) DK0996431T3 (de)
ES (1) ES2218833T3 (de)
WO (1) WO1998057622A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1317272B1 (de) 2000-05-25 2006-04-12 Boehringer Ingelheim International GmbH Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids for the preparation of substances for the treatment of high blood pressure
IL141039A (en) 2001-01-23 2006-10-31 Lycored Natural Prod Ind Ltd The composition for the prevention of atherosclerosis containing carotenoids and use for the preparation of drugs to inhibit LDL oxidation
WO2003017992A2 (en) * 2001-08-22 2003-03-06 Cambridge Theranostics Ltd Means for treatment of atherosclerosis
GB2380481B (en) * 2001-08-22 2003-12-03 Cambridge Theranostics Ltd Means for treatment of atherosclerosis
JP4818637B2 (ja) * 2005-05-02 2011-11-16 日本メナード化粧品株式会社 低密度リポタンパク質（ｌｄｌ）酸化抑制剤
DK2221059T3 (en) * 2007-10-25 2018-03-12 Nutri Co Ltd Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and / or c-reactive protein in blood
EP2952104A1 (de) 2014-06-05 2015-12-09 Böhm, Kirsten Zusammensetzung und Verfahren zur Vermeidung von Beschädigungen von menschlichen Zellen durch ionisierende Strahlung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64837A (en) * 1990-10-01 1994-03-28 Brigham & Womens Hospital Preparatives of beta-carotine and those of vitamine e having ulceration inhibiting effect
WO1995035099A1 (en) * 1994-06-20 1995-12-28 Kv Pharmaceutical Company Vitamin/nutrient dosage regimentation
WO1996019215A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Compositions of tocopherol and beta-carotene
AU705467C (en) * 1994-12-22 2002-12-19 Cognis Corporation Pharmaceutical compositions comprising lycopene

Also Published As

Publication number Publication date
AU8031998A (en) 1999-01-04
DK0996431T3 (da) 2004-04-26
EP0996431A1 (de) 2000-05-03
DE69822834D1 (de) 2004-05-06
WO1998057622A1 (en) 1998-12-23
ES2218833T3 (es) 2004-11-16
JP2002504928A (ja) 2002-02-12
DE69822834T2 (de) 2005-03-24
EP0996431B1 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
BR9908222A (pt) Composições para regular a aparência da pele
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
BG98933A (en) Cooled and atomized nabumetone
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AU6408298A (en) Essential oil composition
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
ES2081823T3 (es) Agente para la aplicacion transdermica, que contiene gestoden.
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
BR9813083A (pt) Composições à base de extratos de vegetais
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
DE69822834D1 (de) Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
NZ333966A (en) Use of 1-nonen-3-one as a flavouring agent
ES2126772T3 (es) Composiciones hipocolesterolemicas dieteticas que comprenden proteinas de soja y sitosteroles.
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
MD970269A (en) Clavulanates
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
IL121112A (en) Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
WO1998057622B1 (en) Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
HUT67301A (en) Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties